<?xml version='1.0' encoding='utf-8'?>
<document id="10901703"><sentence text="Concurrent flavin-containing monooxygenase down-regulation and cytochrome P-450 induction by dietary indoles in rat: implications for drug-drug interaction."><entity charOffset="11-17" id="DDI-PubMed.10901703.s1.e0" text="flavin" /></sentence><sentence text="Our laboratory has previously shown that dietary administration of indole-3-carbinol (I3C) to male Fischer 344 rats has the very unusual property of inducing hepatic levels of a number of cytochrome P450s (CYPs), especially CYP1A1, while markedly inhibiting the levels of flavin-containing monooxygenase (FMO) 1 protein and its catalytic activity"><entity charOffset="67-84" id="DDI-PubMed.10901703.s2.e0" text="indole-3-carbinol" /><entity charOffset="272-278" id="DDI-PubMed.10901703.s2.e1" text="flavin" /><pair ddi="false" e1="DDI-PubMed.10901703.s2.e0" e2="DDI-PubMed.10901703.s2.e0" /><pair ddi="false" e1="DDI-PubMed.10901703.s2.e0" e2="DDI-PubMed.10901703.s2.e1" /></sentence><sentence text=" We hypothesized that rats fed I3C or 3,3'-diindolylmethane (DIM), one of its major acid condensation products formed in vivo, should exhibit a marked shift in the metabolic profiles of drugs or xenobiotics that are substrates for both monooxygenase systems"><entity charOffset="38-59" id="DDI-PubMed.10901703.s3.e0" text="3,3'-diindolylmethane" /></sentence><sentence text=" Male rats were fed AIN-76A powdered diets containing 0, 1000, or 2500 ppm I3C or DIM for 4 weeks" /><sentence text=" Dietary I3C and DIM reduced FMO1 protein levels (8% reduction with I3C and 84% with DIM at 1000 ppm, and 90% reduction with I3C and 97% with DIM at 2500 ppm) in hepatic microsomes" /><sentence text=" The ratio of FMO (N-oxygenation)- to CYP (N-demethylation)-mediated metabolism of N,N-dimethylaniline decreased in liver microsomes from I3C- or DIM-fed rats from near unity to 0"><entity charOffset="83-102" id="DDI-PubMed.10901703.s6.e0" text="N,N-dimethylaniline" /></sentence><sentence text="02 at the highest dietary doses" /><sentence text=" FMO-mediated N-oxygenation (nicotine N-1'-oxide) was decreased, whereas CYP-mediated (nornicotine and nicotine delta (1,5)-iminium ion) metabolism of nicotine was unchanged in liver microsomes from rats fed I3C or DIM"><entity charOffset="29-48" id="DDI-PubMed.10901703.s8.e0" text="nicotine N-1'-oxide" /><entity charOffset="87-98" id="DDI-PubMed.10901703.s8.e1" text="nornicotine" /><entity charOffset="103-111" id="DDI-PubMed.10901703.s8.e2" text="nicotine" /><entity charOffset="118-135" id="DDI-PubMed.10901703.s8.e3" text="(1,5)-iminium ion" /><entity charOffset="151-159" id="DDI-PubMed.10901703.s8.e4" text="nicotine" /><pair ddi="false" e1="DDI-PubMed.10901703.s8.e0" e2="DDI-PubMed.10901703.s8.e0" /><pair ddi="false" e1="DDI-PubMed.10901703.s8.e0" e2="DDI-PubMed.10901703.s8.e1" /><pair ddi="false" e1="DDI-PubMed.10901703.s8.e0" e2="DDI-PubMed.10901703.s8.e2" /><pair ddi="false" e1="DDI-PubMed.10901703.s8.e0" e2="DDI-PubMed.10901703.s8.e3" /><pair ddi="false" e1="DDI-PubMed.10901703.s8.e0" e2="DDI-PubMed.10901703.s8.e4" /><pair ddi="false" e1="DDI-PubMed.10901703.s8.e1" e2="DDI-PubMed.10901703.s8.e1" /><pair ddi="false" e1="DDI-PubMed.10901703.s8.e1" e2="DDI-PubMed.10901703.s8.e2" /><pair ddi="false" e1="DDI-PubMed.10901703.s8.e1" e2="DDI-PubMed.10901703.s8.e3" /><pair ddi="false" e1="DDI-PubMed.10901703.s8.e1" e2="DDI-PubMed.10901703.s8.e4" /><pair ddi="false" e1="DDI-PubMed.10901703.s8.e2" e2="DDI-PubMed.10901703.s8.e2" /><pair ddi="false" e1="DDI-PubMed.10901703.s8.e2" e2="DDI-PubMed.10901703.s8.e3" /><pair ddi="false" e1="DDI-PubMed.10901703.s8.e2" e2="DDI-PubMed.10901703.s8.e4" /><pair ddi="false" e1="DDI-PubMed.10901703.s8.e3" e2="DDI-PubMed.10901703.s8.e3" /><pair ddi="false" e1="DDI-PubMed.10901703.s8.e3" e2="DDI-PubMed.10901703.s8.e4" /></sentence><sentence text=" Similarly, the ratio of FMO to CYP metabolites of tamoxifen decreased due to a reduction in N-oxygenation"><entity charOffset="51-60" id="DDI-PubMed.10901703.s9.e0" text="tamoxifen" /></sentence><sentence text=" This study demonstrates alteration of FMO- and CYP-mediated drug metabolism in vitro by dietary I3C or DIM and suggests the potential for altered toxicity of tamoxifen and nicotine in vivo"><entity charOffset="159-168" id="DDI-PubMed.10901703.s10.e0" text="tamoxifen" /><entity charOffset="173-181" id="DDI-PubMed.10901703.s10.e1" text="nicotine" /><pair ddi="false" e1="DDI-PubMed.10901703.s10.e0" e2="DDI-PubMed.10901703.s10.e0" /><pair ddi="false" e1="DDI-PubMed.10901703.s10.e0" e2="DDI-PubMed.10901703.s10.e1" /></sentence><sentence text="" /></document>